Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Off-label uses of drugs for depression
Sigrid S. Skånland, Artur Cieślar‐Pobuda
European Journal of Pharmacology (2019) Vol. 865, pp. 172732-172732
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
Amber N. Edinoff, Haseeb A. Akuly, Tony A. Hanna, et al.
Neurology International (2021) Vol. 13, Iss. 3, pp. 387-401
Open Access | Times Cited: 226
Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness
William H. Roughan, Adrián I. Campos, Luis M. García‐Marín, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 90
Depression and Pain: Use of Antidepressants
Herlinda Bonilla‐Jaime, José A. Sánchez-Salcedo, Maribel M. Estévez-Cabrera, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 2, pp. 384-402
Open Access | Times Cited: 84
Association between ultra-processed foods and recurrence of depressive symptoms: the Whitehall II cohort study
Husnain Arshad, Jenny Head, Felice N. Jacka, et al.
Nutritional Neuroscience (2023) Vol. 27, Iss. 1, pp. 42-54
Open Access | Times Cited: 31
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure‐Activity Relationships
Ravi Kumar, Bhaskar Sahu, Shelly Pathania, et al.
ChemMedChem (2021) Vol. 16, Iss. 12, pp. 1878-1901
Closed Access | Times Cited: 47
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Yaser Pashaei
Journal of Clinical Neuroscience (2021) Vol. 88, pp. 163-172
Open Access | Times Cited: 42
Pharmacotherapy
Anna Feeney, George I. Papakostas
Psychiatric Clinics of North America (2023) Vol. 46, Iss. 2, pp. 277-290
Closed Access | Times Cited: 17
Paroxetine—Overview of the Molecular Mechanisms of Action
Magdalena Kowalska, Jacek Nowaczyk, Łukasz Fijałkowski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1662-1662
Open Access | Times Cited: 37
An Exploration of the Interplay Between Caffeine and Antidepressants Through the Lens of Pharmacokinetics and Pharmacodynamics
John Truong, Noor Abu-Suriya, Daniel Tory, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2025)
Open Access
The risk associated with ultra-processed food intake on depressive symptoms and mental health in older adults: a target trial emulation
Belayneh Mengist, Mojtaba Lotfaliany, Julie A. Pasco, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Anesthetic Considerations for Patients on Psychotropic Drug Therapies
Monica W. Harbell, Catalina Dumitrascu, Layne Bettini, et al.
Neurology International (2021) Vol. 13, Iss. 4, pp. 640-658
Open Access | Times Cited: 26
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study
Anna Feeney, Rebecca S. Hock, Marlene P. Freeman, et al.
European Neuropsychopharmacology (2021) Vol. 49, pp. 122-132
Open Access | Times Cited: 24
Therapeutic potential of plant iridoids in depression: a review
Yaoyao Kou, Zhihao Li, Tong Yang, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 2167-2181
Open Access | Times Cited: 16
Machine Learning Applications for Drug Repurposing
Bancha Yingngam
(2024), pp. 251-294
Closed Access | Times Cited: 3
Subphenotyping depression using machine learning and electronic health records
Zhenxing Xu, Fei Wang, Prakash Adekkanattu, et al.
Learning Health Systems (2020) Vol. 4, Iss. 4
Open Access | Times Cited: 21
Serotonin Syndrome/Serotonin Toxicity
Cynthia Talton
Federal practitioner (2020), Iss. Vol 37 No 10
Open Access | Times Cited: 21
Treatment indications and potential off‐label use of antidepressants among older adults: A population‐based descriptive study in Denmark
Kazi Ishtiak‐Ahmed, Xiaoqin Liu, Kaj Sparle Christensen, et al.
International Journal of Geriatric Psychiatry (2022) Vol. 37, Iss. 12
Open Access | Times Cited: 12
Effects of different antidepressant classes on dental implant failure: A retrospective clinical study
Abeer Essam Hakam, Gabriela S. Vila, Poliana Mendes Duarte, et al.
Journal of Periodontology (2020) Vol. 92, Iss. 2, pp. 196-204
Closed Access | Times Cited: 19
Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study
Marek Krzystanek, Artur Pałasz
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 326-326
Open Access | Times Cited: 13
A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders
Bhupinder Kumar, Naveen Kumar, Amandeep Thakur, et al.
Current Drug Targets (2022) Vol. 23, Iss. 7, pp. 729-751
Closed Access | Times Cited: 8
Depression and the risk of hospitalization in type 2 diabetes patients: A nested case-control study accounting for non-persistence to antidiabetic treatment
Isabelle Tardif, Line Guénette, Arsène Zongo, et al.
Diabetes & Metabolism (2022) Vol. 48, Iss. 4, pp. 101334-101334
Open Access | Times Cited: 8
Major depression recurrence is associated with differences in obesity-related traits in women, but not in men
Urs Bannert, Ulrike Siewert‐Markus, Johanna Klinger-König, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 1
Pain Management in Children
Leah Margalit Winters Webb, Erin Adams, Billy McElroy, et al.
(2024), pp. 247-269
Closed Access | Times Cited: 1
Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes: A nested case-control study
Carlotta Lunghi, Arsène Zongo, Isabelle Tardif, et al.
Diabetes Research and Clinical Practice (2020) Vol. 171, pp. 108566-108566
Closed Access | Times Cited: 12
Insomnia and other sleep disorders in dermatology patients: A questionnaire-based study with 634 patients
Rianna Tamschick, Alexander A. Navarini, Werner Strobel, et al.
Clinics in Dermatology (2021) Vol. 39, Iss. 6, pp. 996-1004
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top